NEFL and Parkinson disease: When we determined CSF-NfL, a known marker for several neurodegenerative diseases, reflecting the neuroaxonal damage (Holmberg et al., 1998; Petzold, 2005), we obtained a highly significant increase of NfL levels in patients with DLB and MSA compared to those with PD and controls.